About this item:

103 Views | 82 Downloads

Author Notes:

Correspondence: Shaomei Wang, Regenerative Medicine Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, AHSP-8107, Los Angeles, CA 90048; shaomei.wang@cshs.org

The authors thank Terrence Town, PhD, and Tara M. Weitz, PhD (University of Southern California, Keck School of Medicine, Los Angeles, CA) for sharing tissue from 14-month-old AD rats.

We thank Claudia Tan and Mary Bessell for proofreading this manuscript, and Carol Church and Jeanette Espinosa for their administrative support at the Alzheimer's Disease Research Center at the University of Southern California.

Disclosures: none.

Subjects:

Research Funding:

Supported by Grants NIH R01 EY020488-02, W81XWH-DOD, the Lincy Foundation, FFB, the Fund from the Regenerative Medicine Institute at Cedars-Sinai Medical Center, the National Institute of Aging Grant P50-AG05142, and NIH R01 EY03040 (FNR-C and AAS).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Ophthalmology
  • Alzheimer's disease
  • choroidal thickness
  • visual acuity
  • retinal pigment epithelium
  • Retinal pigment epithelium
  • Optical coherence tomography
  • Mild cognitive impairment
  • Choroidal thickness
  • Complement activation
  • Mouse model
  • Amyloid deposition
  • Cell changes
  • Visual impairment
  • Senile dementia

Ocular Changes in TgF344-AD Rat Model of Alzheimer's Disease

Tools:

Journal Title:

Investigative Ophthalmology & Visual Science

Volume:

Volume 55, Number 1

Publisher:

, Pages 523-534

Type of Work:

Article | Final Publisher PDF

Abstract:

Purpose: Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive decline in learning, memory, and executive functions. In addition to cognitive and behavioral deficits, vision disturbances have been reported in early stage of AD, well before the diagnosis is clearly established. To further investigate ocular abnormalities, a novel AD transgenic rat model was analyzed. Methods: Transgenic (Tg) rats (TgF344-AD) heterozygous for human mutant APPswe/PS1ΔE9 and age-matched wild type (WT) rats, as well as 20 human postmortem retinal samples from both AD and healthy donors were used. Visual function in the rodent was analyzed using the optokinetic response. Immunohistochemistry on retinal and brain sections was used to detect various markers including amyloid-β (Aβ) plaques. Results As expected, Aβ plaques were detected in the hippocampus, cortex, and retina of Tg rats. Plaque-like structures were also found in two AD human whole-mount retinas. The choroidal thickness was significantly reduced in both Tg rat and in AD human eyes when compared with age-matched controls. Tg rat eyes also showed hypertrophic retinal pigment epithelial cells, inflammatory cells, and upregulation of complement factor C3. Although visual acuity was lower in Tg than in WT rats, there was no significant difference in the retinal ganglion cell number and retinal vasculature. Conclusions: Further studies are needed to elucidate the significance and mechanisms of this pathological change and luminance threshold recording from the superior colliculus.

Copyright information:

© 2014 The Association for Research in Vision and Ophthalmology, Inc.

Export to EndNote